CS
NVLN

Credit Suisse’s Novelion Therapeutics Inc. Common Shares NVLN Stock Holding History

Credit Suisse’s Portfolio NVLN Stock Details NVLN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-32,137
Closed -$225K – 3715
2017
Q3 		$225K Buy
32,137
+7,418
+30% +$51.9K ﹤0.01% 3397
2017
Q2 		$228K Buy
24,719
+3,059
+14% +$28.2K ﹤0.01% 3193
2017
Q1 		$233K Sell
21,660
-6,726
-24% -$72.4K ﹤0.01% 3219
2016
Q4 		$239K Buy
+28,386
New +$239K ﹤0.01% 3386